-
The FDA has approved a new combination product for the treatment of type 2 diabetes mellitus. Sitagliptin, the recently approved dipeptidyl peptidase-4 (DPP-4) inhibitor is combined with metformin in two different dose configurations. Sitagliptin/metformin is marketed by Merck & Co., Inc as Janumet.
-
Quinolone-resistant neisseria gonorrhea (QRNG) continues to spread with alarming frequency across the United States. Quinolones were first recommended for the treatment of GC by the CDC in 1986.
-
High dose PPI infusion prior to endoscopy accelerated resolution of the signs of ulcer bleeding and significantly reduced the need for endoscopic hemostasis therapy.
-
There is a surge of coronary deaths following influenza epidemics, which strengthens the importance of flu vaccinations for those at risk for cardiovascular events.
-
Hospital legends about the relative availability (or unavailability) of services/personnel on weekends vs weekdays often lead to jocularity about the wisdom of choosing one's day to be admitted to the hospital carefully!
-
Occipital nerve stimulation appears to decrease the cluster pain and attack frequency in most, but not all, patients with chronic drug-resistant cluster headaches.
-
Intensive intervention using Advance Practice Nurses reduced the use of side rails on nursing home beds and lowered the rate of bed-related falls and injuries.
-
National Institutes of Neurological Disorders and Stroke. Migraine headaches. Altern Med Alert 2007;10(suppl 6):S1-S2.
-
Greenfield RH. Tea time will never be the same again: Tea and milk. Altern Med Alert 2007;10(6):70-71. Greenfield RH. Adults, herbs, and evidence-based medicine. Altern Med Alert 2007;10(6):71-72. Greenfield RH. One does not equal twoCinnamon and diabetes mellitus. Altern Med Alert 2007;10(6):72.
-
O'Mathuna DP. Antioxidant vitamins, immunity, and endurance exercise. Altern Med Alert 2007;10(6):66-69.